{"id":452924,"date":"2019-12-01T16:28:01","date_gmt":"2019-12-01T16:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=452924"},"modified":"2019-12-01T16:28:01","modified_gmt":"2019-12-01T16:28:01","slug":"wound-biologics-market-is-advancing-at-a-tremendous-cagr-of-44-by-2026-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/wound-biologics-market-is-advancing-at-a-tremendous-cagr-of-44-by-2026-grand-view-research-inc_452924.html","title":{"rendered":"Wound Biologics Market Is Advancing At A Tremendous CAGR Of 44% By 2026: Grand View Research, Inc"},"content":{"rendered":"
\"Wound<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The global wound biologics market size was valued at USD 3.13 billion in 2018 and is expected to grow at a CAGR of 9.4% over the forecast period.<\/div>\n

The global wound biologics market<\/a> size is expected to reach USD 6.43 billion by 2026, according to a new report by Grand View Research, Inc. is expected to grow at a CAGR of 9.4% over the forecast period. The rising geriatric population, introduction of technologically advanced products, and increasing cases of burns are the key driving factors for this market.<\/p>\n

The wound biologic therapy helps in restoring innate repair mechanisms of the patients. It also involves application of active biological agents such as plant-derived biomolecules. These biological agents has antimicrobial, anti-inflammatory attributes, and antioxidant properties that helps in rapid healing of wounds. In addition, the biologic dressing restricts water, electrolyte, protein, and heat loss and allows minimal risk of contamination. It also enables autolytic debridement and develop a granular wound bed, thereby promoting rapid wound healing.<\/p>\n

The wound biologics treatment is very much effective in healing chronic and acute wounds. The increasing cases of burn wounds and diabetic foot ulcers across the globe are anticipated to be the major driving factor for this market growth. For instance, as per a report published by the National Center for Biotechnology Information (NCBI), in 2019, the global prevalence of Diabetic Foot Ulcers (DFU) was 6.3% in 2018 and North America reported the highest DFU prevalence rate of 13.0% and Oceania had the lowest prevalence of 3.0%. Since, wound biologics allows rapid and effective healing, thus increasing incidence of chronic wounds are expected to surge the demand for wound biologics products, thereby propelling the market growth over the forecast period.<\/p>\n

Browse Details of Report, Please Visit @ <\/strong>https:\/\/www.grandviewresearch.com\/industry-analysis\/wound-biologics-market<\/a><\/strong><\/p>\n

\"U.S.<\/p>\n

Key Takeaways from the report:<\/strong><\/p>\n